Association Between Vitamin D and Adrenal Parameters with Metabolic and Inflammatory Markers in Polycystic Ovary Syndrome
Authors:
Open Access
- 8 March 2019
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 3968
Abstract
Vitamin D deficiency has been related with metabolic alterations in polycystic ovary syndrome (PCOS). As well, hyperactivation of adrenal axis can be programmed early in life and could be related later with PCOS development. Our aim was to establish the relationship between vitamin D and adrenal parameters with metabolic alterations and inflammation markers in PCOS. In 73 patients and 33 controls, 25-hydroxyvitamin D (25-OH-D), total and bioavailable testosterone (TT and bioT), androstenedione (A4), SHBG, cortisol, insulin, and C-reactive protein (hs-CRP) were determined; HOMA and lipid accumulation product (LAP) index were calculated. All parameters were higher in patients than in controls, except for SHBG and 25-OH-D which were lower. Binary regression analysis showed that differences in TT, bioT, A4, insulin and HOMA were independent of body mass index and waist circumference but SHBG, hs-CRP, LAP and 25-OH-D were related to body weight and fat distribution. Binary logistic regression analysis showed that cortisol and 25-OH-D could be associated to PCOS development. Correlations found between LAP and insulin, HOMA and hs-CRP confirm it is a good indicator of metabolic complications. Vitamin D and cortisol association to PCOS development justifies future research to understand the role of vitamin D in PCOS and analyze patient’s perinatal history and its possible relationship with hyperactivation of adrenal axis in adult life.Keywords
Funding Information
- Universidad de Buenos Aires (UBACYT-IC 20720150200006BA01, UBACYT-IC 20720150200006BA01, UBACYT-IC 20720150200006BA01, UBACYT-IC 20720150200006BA01, UBACYT-IC 20720150200006BA01)
This publication has 44 references indexed in Scilit:
- Evaluation of hs-CRP and visseral adiposity index in patients with policystic ovary syndrome by clinical and laboratory findingsEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2016
- Adipose tissue dysfunction, adipokines, and low-grade chronic inflammation in polycystic ovary syndromeReproduction, 2015
- Polycystic ovary syndrome: reviewing diagnosis and management of metabolic disturbancesArchives of Endocrinology and Metabolism, 2014
- Clinical and Biochemical Profiles according to Homeostasis Model Assessment-insulin Resistance (HOMA-IR) in Korean Women with Polycystic Ovary SyndromeJournal of Menopausal Medicine, 2014
- The hypothalamic–pituitary–adrenal axis and sex hormones in chronic stress and obesity: pathophysiological and clinical aspectsAnnals of the New York Academy of Sciences, 2012
- Insulin Resistance and Lipid Accumulation Product in Corelation to Body Mass Index in Women with Polycystic Ovary SyndromeMedical Archives, 2012
- The role of low-grade inflammation in the polycystic ovary syndromeMolecular and Cellular Endocrinology, 2011
- Lipid accumulation product index: a reliable marker of cardiovascular risk in polycystic ovary syndromeHuman Reproduction, 2009
- The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force reportFertility and Sterility, 2009
- Nonclassic Actions of Vitamin DThe Journal of Clinical Endocrinology & Metabolism, 2009